Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in <scp>AML</scp> : Results of the <scp>AML21</scp> randomized phase <scp>III</scp> trial of the <scp>EORTC</scp> Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto ( <scp>GIMEMA)</scp> and German <scp>MDS</scp> Study Group

Julia Stomper, Michal Kicinski, Tobias Ma, Thomas Meyer, Sylvain Chantepie, Richard Noppeney, Mario Luppi, Ernesta Audisio, Laimonas Griškevičius, Andreas Neubauer, Robin Foà, Walter J. F. M. Van der Velden, Anna Candoni, Radovan Vrhovac, Gianluca Gaidano, Catharina Van Elssen, Mels Hoogendoorn, Maurizio Musso, Attilio Olivieri, Christian Junghanß, Emmanuel Bissé, Stephanie Antunes, Frédéric Baron, Adriano Venditti, Joop H. Jansen, Pierre W. Wijermans, Gerwin Huls, Michael Lübbert

Open source

DOI: 10.1111/bjh.70874
Published: 2026-11-03
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70874,
  title = {Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in
                    <scp>AML</scp>
                    : Results of the
                    <scp>AML21</scp>
                    randomized phase
                    <scp>III</scp>
                    trial of the
                    <scp>EORTC</scp>
                    Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (
                    <scp>GIMEMA)</scp>
                    and German
                    <scp>MDS</scp>
                    Study Group},
  author = {Julia Stomper and Michal Kicinski and Tobias Ma and Thomas Meyer and Sylvain Chantepie and Richard Noppeney and Mario Luppi and Ernesta Audisio and Laimonas Griškevičius and Andreas Neubauer and Robin Foà and Walter J. F. M. Van der Velden and Anna Candoni and Radovan Vrhovac and Gianluca Gaidano and Catharina Van Elssen and Mels Hoogendoorn and Maurizio Musso and Attilio Olivieri and Christian Junghanß and Emmanuel Bissé and Stephanie Antunes and Frédéric Baron and Adriano Venditti and Joop H. Jansen and Pierre W. Wijermans and Gerwin Huls and Michael Lübbert},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70874},
  url = {https://doi.org/10.1111/bjh.70874}
}

RIS

TY  - JOUR
TI  - Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in
                    <scp>AML</scp>
                    : Results of the
                    <scp>AML21</scp>
                    randomized phase
                    <scp>III</scp>
                    trial of the
                    <scp>EORTC</scp>
                    Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (
                    <scp>GIMEMA)</scp>
                    and German
                    <scp>MDS</scp>
                    Study Group
AU  - Julia Stomper
AU  - Michal Kicinski
AU  - Tobias Ma
AU  - Thomas Meyer
AU  - Sylvain Chantepie
AU  - Richard Noppeney
AU  - Mario Luppi
AU  - Ernesta Audisio
AU  - Laimonas Griškevičius
AU  - Andreas Neubauer
AU  - Robin Foà
AU  - Walter J. F. M. Van der Velden
AU  - Anna Candoni
AU  - Radovan Vrhovac
AU  - Gianluca Gaidano
AU  - Catharina Van Elssen
AU  - Mels Hoogendoorn
AU  - Maurizio Musso
AU  - Attilio Olivieri
AU  - Christian Junghanß
AU  - Emmanuel Bissé
AU  - Stephanie Antunes
AU  - Frédéric Baron
AU  - Adriano Venditti
AU  - Joop H. Jansen
AU  - Pierre W. Wijermans
AU  - Gerwin Huls
AU  - Michael Lübbert
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70874
UR  - https://doi.org/10.1111/bjh.70874
ER  -

APA

Stomper, J., Kicinski, M., Ma, T., Meyer, T., Chantepie, S., Noppeney, R., Luppi, M., Audisio, E., Griškevičius, L., Neubauer, A., Foà, R., Velden, W. J. F. M. V. D., Candoni, A., Vrhovac, R., Gaidano, G., Elssen, C. V., Hoogendoorn, M., Musso, M., Olivieri, A., Junghanß, C., Bissé, E., Antunes, S., Baron, F., Venditti, A., Jansen, J. H., Wijermans, P. W., Huls, G., & Lübbert, M. (2026). Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in <scp>AML</scp> : Results of the <scp>AML21</scp> randomized phase <scp>III</scp> trial of the <scp>EORTC</scp> Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto ( <scp>GIMEMA)</scp> and German <scp>MDS</scp> Study Group. British Journal of Haematology. https://doi.org/10.1111/bjh.70874

Source records

crossref · retrieved 2026-11-06T05:25:13.254Z